Palonosetron versus granisetron in combination with aprepitant for the prevention of chemotherapy-induced nausea and vomiting in patients with gynecologic cancer.
about
Evaluation of the efficacy of palonosetron for prevention of chemotherapy-induced nausea and vomiting in patients with gastric cancer treated with S-1 plus cisplatin.Granisetron in the treatment of chemotherapy-induced nausea and vomiting (CINV) - is there still a role after comparison with palonosetron?Antiemetic therapy for non-anthracycline and cyclophosphamide moderately emetogenic chemotherapy.A phase II randomised study to evaluate the efficacy of aprepitant plus palonosetron for preventing delayed-phase CINV associated with TC therapy in gynaecological cancer.
P2860
Palonosetron versus granisetron in combination with aprepitant for the prevention of chemotherapy-induced nausea and vomiting in patients with gynecologic cancer.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Palonosetron versus granisetro ...... ients with gynecologic cancer.
@ast
Palonosetron versus granisetro ...... ients with gynecologic cancer.
@en
type
label
Palonosetron versus granisetro ...... ients with gynecologic cancer.
@ast
Palonosetron versus granisetro ...... ients with gynecologic cancer.
@en
prefLabel
Palonosetron versus granisetro ...... ients with gynecologic cancer.
@ast
Palonosetron versus granisetro ...... ients with gynecologic cancer.
@en
P2093
P2860
P1476
Palonosetron versus granisetro ...... ients with gynecologic cancer.
@en
P2093
Hiroshi Sasaki
Masahide Ohmichi
Masanori Kanemura
Satoe Fujiwara
Satoshi Tsunetoh
Yoshito Terai
P2860
P304
P356
10.3802/JGO.2015.26.4.311
P577
2015-07-20T00:00:00Z